CG
IONS icon

Cutler Group’s Ionis Pharmaceuticals IONS Stock Holding History

Cutler Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,000
Closed -$8K – 4509
2019
Q1 		$8K Buy
6,000
+1,700
+40% +$110K ﹤0.01% 2643
2018
Q4 		$1K Hold
4,300
– – ﹤0.01% 3627
2018
Q3 		$5K Sell
4,300
-500
-10% -$23.5K ﹤0.01% 3047
2018
Q2 		$19K Sell
4,800
-6,200
-56% -$275K ﹤0.01% 2223
2018
Q1 		$59K Sell
11,000
-1,500
-12% -$76.2K 0.01% 1548
2017
Q4 		$30K Sell
12,500
-17,500
-58% -$960K ﹤0.01% 2238
2017
Q3 		$130K Buy
30,000
+1,200
+4% +$62.9K ﹤0.01% 1457
2017
Q2 		$77K Buy
28,800
+9,300
+48% +$433K ﹤0.01% 2087
2017
Q1 		$108K Sell
19,500
-32,500
-63% -$1.46M ﹤0.01% 1662
2016
Q4 		$122K Sell
52,000
-10,200
-16% -$404K ﹤0.01% 1733
2016
Q3 		$216K Buy
62,200
+8,100
+15% +$253K 0.01% 1143
2016
Q2 		$575K Buy
54,100
+2,500
+5% +$80.6K 0.03% 510
2016
Q1 		$553K Sell
51,600
-5,700
-10% -$232K 0.04% 485
2015
Q4 		$275K Buy
+57,300
New +$3.09M 0.02% 942

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cutler Group's IONS Position: Q4 2022 in Review

Cutler Group sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 100 shares — an estimated $4K sold.

Cutler Group first reported a position in IONS in Q4 2015 and held it in 19 quarters. The position peaked at $3.43M in Q4 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Cutler Group reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 100 Ionis Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Cutler Group first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Cutler Group's Ionis Pharmaceuticals position peaked at $3.43M in Q4 2015.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.